NICHOLS et al. V. TABAKOFF et al. - Page 38




            Interference No. 104,522 Paper108                                                                        
            Nichols v. Tabakoff Page 38                                                                              
            78. Furthermore, although Dr. Nichols testified that he did not remember Leeson (Ex                      
            2016) being among the synthesis papers sent to him by Dr. Snell (NR, p. 72,1. 23 - p.                    
            73,1. 12), Dr. Nichols testified that he used Leeson as the starting point for his synthetic             
            scheme (NR, p. 27, ý% 28-29; p. 27, ýT 13-14).                                                           
            79. In particular, Dr. Nichols testified that he had seen a similar compound described                   
            in a paper by Leeson entitled "4-Amido-2-carboxytetrahydroquinolines. Structure                          
            Activity Relationships for Antagonism at the Glycine Site of the NMDA Receptor." (Ex                     
            2016). Leeson disclosed seven different synthetic schemes (Ld., pp. 1954-1956). For                      
            example, Leeson prepared "[u]reas ...  from reactions of 66 [2-carboxy-5,7-dichloro-4                    
            amidotetrahydroquinoline] with the appropriate isocyanates" (id., p. 1955, c. 1).                        
            80. According to Dr. Nichols,                                                                            
                   The compounds synthesized by Leeson substitute a urea compound onto                               
                   saturated [i.e., aliphatic] rings, whereas the synthesis method of the                            
                   present invention substitutes a urea compound onto an unsaturated [i.e.,                          
                   aromatic] ring. Based on our long experience of working in the lab with                           
                   kynurenates, I can attest that kynurenates behave both chemically and                             
                   biologically different from the tetrahydroquinoline counterparts utilized                         
                   Leeson. The 4-amino group in the kynurenate compound exists as a                                  
                   tautomer with the ring nitrogen, making it unreactive with the isocyanates                        
                   used by Leeson. This is why, as stated in my prior declaration, the                               
                   reaction used by Leeson to synthesize 4-urea substituted                                          
                   tetrahydroquinoline derivatives was not effective in synthesizing the                             
                   compounds of this interference. Exh. 2012, T 30. [NR, p. 20, % 12.]                               
                   In other words, Dr. Nichols appears to think an isocyanate might not react with a                 
            4-amino-2-carboxyquinoline.                                                                              
            81. Nonetheless, on (a) January 20 and (b) February 3, 1994, Dr. Nichols attempted                       
            his first synthetic scheme, i.e., reacting isocyanate with the 4-amino group of two                      
            aromatic ring compounds, i.e., (i) 4-amino-5,7-dichloro-2-carboxyquinoline methyl ester                  







Page:  Previous  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  Next 

Last modified: November 3, 2007